Global Rare Kidney Diseases Market Report 2024

Rare Kidney Diseases Global Market Report 2024 – By Target Indication (IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications), By Type of Molecule ( Small Molecules, Biologics), By Route of administration (Oral, Intravenous, Subcutaneous, Other Routes of Administration) – Market Size, Trends, And Global Forecast 2024-2033

Rare Kidney Diseases Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Rare Kidney Diseases Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Rare Kidney Diseases Market Definition And Segments

Rare kidney disease is a condition where kidneys aren't functioning correctly, waste accumulates in the body, and causes problems with your health. It is a set of renal diseases that have a low frequency in the general population, and these disorders frequently have a genetic or hereditary origin.

The main target indications of rare kidney diseases are IgA nephropathy, lupus nephritis, focal segmental glomerular sclerosis, membranous nephropathy, C3 glomerulopathy, and others. IgA nephropathy is a kidney disease in which antibodies (named IgA) accumulate in kidney tissue causing inflammation, where angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) are used to lower patients' blood pressure and reduce protein loss for slowing the progression of kidney damage, managing symptoms, and preventing complications. The various types of molecules involved are small molecules and biologics that are administered by various routes of administration such as oral, intravenous, subcutaneous, and others.

The rare kidney diseases market covered in this report is segmented –

1) By Target Indication: IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications

2) By Type of Molecule: Small Molecules, Biologics

3) By Route of administration: Oral, Intravenous, Subcutaneous, Other Routes of Administration

The rare kidney diseases market size has grown rapidly in recent years. It will grow from $2.52 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to increased disease recognition, orphan drug designations, patient advocacy and awareness, and global collaborations in research.

The rare kidney diseases market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the emergence of gene therapies, increasing investment in rare disease research, growing collaboration between stakeholders, and global initiatives for rare diseases. Major trends in the forecast period include a patient-centric approach, real-world evidence and data analytics, regulatory developments, telemedicine and remote monitoring, and global health initiatives.

Government Catalysts Fueling Rare Kidney Disease Market Surge

Government initiatives and funding for kidney disorders are expected to propel the growth of the rare kidney disease market going forward. A government initiative and funding are a type of government financial support given to selected entities with ideas or projects that contribute to and improve public services and the economy. The government provides aid in kidney disorders to enhance disease surveillance and improve the quality of life for persons with various kidney diseases by using a comprehensive public health strategy that includes other public health agencies and national organizations. For instance, in July 2022, The United States House Committee on Appropriations, a US-based committee of the House of Representatives, initiated various investment programs to promote kidney health. It includes $8.5 million in funding for the Centers for Disease Control and Prevention's (CDC) chronic kidney disease program to accelerate activities to promote regular kidney disease awareness, diagnosis, and treatment. Further, a living donation investment of $1 million was made to boost the National Living Donor Assistance Center, bringing the total to $8 million in ongoing investment in innovation and research. Therefore, government initiatives and funding for kidney disorders are driving the growth of the rare kidney disease market.

Surging Rare Kidney Diseases Linked To Escalating Chronic Kidney Disease Incidence

The increasing prevalence of chronic kidney disease (CKD) is significantly contributing to the rare kidney disease market. Chronic kidney disease refers to a disorder where the kidneys are damaged and are unable to properly filter blood. The increased prevalence of chronic kidney diseases will increase the chances of the development of rare kidney diseases in patients, which will increase the demand for the therapeutics required for rare kidney diseases. For instance, according to the 2023 report published by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, more than 1 in 7 US adults—about 35.5 million people, or 14%—are estimated to have chronic kidney disease (CKD). Therefore, the increasing prevalence of chronic kidney disease (CKD) will drive the rare kidney disease market.

Major companies operating in the rare kidney diseases market report are Merck & Co. Inc., Novartis AG, Sanofi S.A, AstraZeneca PLC, GlaxoSmithKline PLC, Otsuka Pharmaceutical Co Ltd., Alexion Pharmaceuticals Inc., Horizon Therapeutics plc., Recordati S.p.A., Proteostasis Therapeutics, Amicus Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics, FibroGen Inc., Aurinia Pharmaceuticals Inc., Calliditas Therapeutics AB, Apellis Pharmaceuticals Inc., Protalix Biotherapeutics Inc., ChemoCentryx Inc., Omeros Corporation, Celtaxsys Inc., Corbus Pharmaceuticals Holdings Inc., Chinook Therapeutics Inc., Spyryx Biosciences Inc., OxThera AB, Advicenne Pharma SA, ProQR Therapeutics NV, Reata Pharmaceuticals Inc., Savara Inc.

Innovative Therapies Emerge As Key Catalysts In Rare Kidney Disease Market Evolution

Product innovation is a key trend gaining popularity in the rare kidney disease market. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in September 2022, STADA Arzneimittel AG, a Germany-based company operating in generics, specialty pharma, and non-prescription consumer healthcare products, introduced Kinpeygo (budesonide), the first medicine authorized in the EU for treating rare kidney disease for treating a rare kidney disease immunoglobulin A nephropathy (IgAN). The modified-release budesonide capsules are the first and only approved treatment in the EU for primary IgAN, a rare, progressive autoimmune kidney disease with a high unmet need, with more than 25%-30% of patients eventually developing terminal kidney insufficiency requiring dialysis or kidney transplantation.

Pioneering Non-Immunosuppressive Therapies Revolutionize Rare Kidney Disease Treatment Landscape

Major companies operating in the rare kidney diseases market are focusing on developing non-immunosuppressive therapy for treating rare kidney diseases. Non-immunosuppressive therapy is a unique treatment that can treat patients with progressive kidney diseases which is not possible for regular therapies used for treating rare kidney diseases. For instance, in February 2023, Travere Therapeutics a US-based biopharmaceutical company, launched sparsentan which is commercially known as Filspari. the drug is the first non-immunosuppressive therapy approved for primary immunoglobulin A nephropathy (IgAN). With a distinct mode of action, Filspari functions by obstructing angiotensin and endothelin receptors. This characteristic sets Filspari apart from angiotensin-targeting ACE inhibitors and ARBs, well-known medications primarily prescribed to treat hypertension that have been repurposed for the treatment of IgAN due to their capacity to lower blood pressure in the kidney.

AstraZeneca Expands Rare Kidney Disease Portfolio With Acquisition Of CinCor Pharma Inc.

In February 2023, AstraZeneca Pharmaceuticals LP, a US-based biopharmaceutical company, acquired CinCor Pharma Inc. for $1.8 billion. Through this acquisition, AstraZeneca Pharmaceuticals LP aims to strengthen its portfolio in chronic renal illness and uncontrolled hypertension. CinCor Inc. is a US-based clinical-stage biopharmaceutical company that offers medication for rare kidney diseases.

North America was the leading region in the rare kidney disease market in 2023. The regions covered in the rare kidney diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rare kidney diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rare kidney disease market includes revenues earned by entities by providing services clinical evaluation, genetic counseling, genetic screening, specific testing, molecular diagnosis, hemodialysis, and peritoneal dialysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The rare kidney diseases market research report is one of a series of new reports from The Business Research Company that provides Rare Kidney Diseases market statistics, including Rare Kidney Diseases industry global market size, regional shares, competitors with a Rare Kidney Diseases market share, detailed Rare Kidney Diseases market segments, market trends, and opportunities, and any further data you may need to thrive in the Rare Kidney Diseases industry. This Rare Kidney Diseases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rare Kidney Diseases Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $2.8 billion
Revenue Forecast In 2033 $4.07 billion
Growth Rate CAGR of 9.8% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Target Indication: IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications
2) By Type of Molecule: Small Molecules, Biologics
3) By Route of administration: Oral, Intravenous, Subcutaneous, Other Routes of Administration
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Merck & Co. Inc.; Novartis AG; Sanofi S.A; AstraZeneca plc; GlaxoSmithKline plc; Otsuka Pharmaceutical Co Ltd.; Alexion Pharmaceuticals Inc.; Horizon Therapeutics plc.; Recordati S.p.A.; Proteostasis Therapeutics; Amicus Therapeutics Inc.; Akebia Therapeutics Inc.; Travere Therapeutics; FibroGen Inc.; Aurinia Pharmaceuticals Inc.; Calliditas Therapeutics AB; Apellis Pharmaceuticals Inc.; Protalix Biotherapeutics Inc.; ChemoCentryx Inc.; Omeros Corporation; Celtaxsys Inc.; Corbus Pharmaceuticals Holdings Inc.; Chinook Therapeutics Inc.; Spyryx Biosciences Inc.; OxThera AB; Advicenne Pharma SA; ProQR Therapeutics NV; Reata Pharmaceuticals Inc.; Savara Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rare Kidney Diseases Market Characteristics

    3. Rare Kidney Diseases Market Trends And Strategies

    4. Rare Kidney Diseases Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Rare Kidney Diseases Market Size and Growth

    5.1. Global Rare Kidney Diseases Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Rare Kidney Diseases Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Rare Kidney Diseases Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Rare Kidney Diseases Market Segmentation

    6.1. Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    IgA Nephropathy

    Lupus Nephritis

    Focal Segmental Glomerular Sclerosis

    Membranous Nephropathy

    C3 Glomerulopathy

    Other Target Indications

    6.2. Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Small Molecules

    Biologics

    6.3. Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Intravenous

    Subcutaneous

    Other Routes of Administration

    7. Rare Kidney Diseases Market Regional And Country Analysis

    7.1. Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Rare Kidney Diseases Market

    8.1. Asia-Pacific Rare Kidney Diseases Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Rare Kidney Diseases Market

    9.1. China Rare Kidney Diseases Market Overview

    9.2. China Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Rare Kidney Diseases Market

    10.1. India Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Rare Kidney Diseases Market

    11.1. Japan Rare Kidney Diseases Market Overview

    11.2. Japan Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Rare Kidney Diseases Market

    12.1. Australia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Rare Kidney Diseases Market

    13.1. Indonesia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Rare Kidney Diseases Market

    14.1. South Korea Rare Kidney Diseases Market Overview

    14.2. South Korea Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Rare Kidney Diseases Market

    15.1. Western Europe Rare Kidney Diseases Market Overview

    15.2. Western Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Rare Kidney Diseases Market

    16.1. UK Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Rare Kidney Diseases Market

    17.1. Germany Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Rare Kidney Diseases Market

    18.5. France Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Rare Kidney Diseases Market

    19.9. Italy Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Rare Kidney Diseases Market

    20.13. Spain Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Rare Kidney Diseases Market

    21.1. Eastern Europe Rare Kidney Diseases Market Overview

    21.2. Eastern Europe Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Rare Kidney Diseases Market

    22.1. Russia Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Rare Kidney Diseases Market

    23.1. North America Rare Kidney Diseases Market Overview

    23.2. North America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Rare Kidney Diseases Market

    24.1. USA Rare Kidney Diseases Market Overview

    24.2. USA Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Rare Kidney Diseases Market

    25.1. Canada Rare Kidney Diseases Market Overview

    25.2. Canada Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Rare Kidney Diseases Market

    26.1. South America Rare Kidney Diseases Market Overview

    26.2. South America Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Rare Kidney Diseases Market

    27.1. Brazil Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Rare Kidney Diseases Market

    28.1. Middle East Rare Kidney Diseases Market Overview

    28.2. Middle East Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Rare Kidney Diseases Market

    29.1. Africa Rare Kidney Diseases Market Overview

    29.2. Africa Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Rare Kidney Diseases Market Competitive Landscape And Company Profiles

    30.1. Rare Kidney Diseases Market Competitive Landscape

    30.2. Rare Kidney Diseases Market Company Profiles

    30.2.1. Merck & Co. Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novartis AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi S.A

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. AstraZeneca plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. GlaxoSmithKline plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Rare Kidney Diseases Market Other Major And Innovative Companies

    31.1. Otsuka Pharmaceutical Co Ltd.

    31.2. Alexion Pharmaceuticals Inc.

    31.3. Horizon Therapeutics plc.

    31.4. Recordati S.p.A.

    31.5. Proteostasis Therapeutics

    31.6. Amicus Therapeutics Inc.

    31.7. Akebia Therapeutics Inc.

    31.8. Travere Therapeutics

    31.9. FibroGen Inc.

    31.10. Aurinia Pharmaceuticals Inc.

    31.11. Calliditas Therapeutics AB

    31.12. Apellis Pharmaceuticals Inc.

    31.13. Protalix Biotherapeutics Inc.

    31.14. ChemoCentryx Inc.

    31.15. Omeros Corporation

    32. Global Rare Kidney Diseases Market Competitive Benchmarking

    33. Global Rare Kidney Diseases Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Rare Kidney Diseases Market

    35. Rare Kidney Diseases Market Future Outlook and Potential Analysis

    35.1 Rare Kidney Diseases Market In 2028 - Countries Offering Most New Opportunities

    35.2 Rare Kidney Diseases Market In 2028 - Segments Offering Most New Opportunities

    35.3 Rare Kidney Diseases Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Merck & Co. Inc. Financial Performance
  • Table 75: Novartis AG Financial Performance
  • Table 76: Sanofi S.A Financial Performance
  • Table 77: AstraZeneca plc Financial Performance
  • Table 78: GlaxoSmithKline plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Rare Kidney Diseases Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Rare Kidney Diseases Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Rare Kidney Diseases Market, Segmentation By Target Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Rare Kidney Diseases Market, Segmentation By Type of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Rare Kidney Diseases Market, Segmentation By Route of administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Merck & Co. Inc. Financial Performance
  • Figure 75: Novartis AG Financial Performance
  • Figure 76: Sanofi S.A Financial Performance
  • Figure 77: AstraZeneca plc Financial Performance
  • Figure 78: GlaxoSmithKline plc Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Veterinary Anti-infectives Global Market Report 2024 – By Drug Class (Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Other Drug Classes), By Species Type (Livestock Animals, Companion Animals), By Mode Of Administration (Oral, Parenteral, Topical), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies, Others Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Animal Antibiotics and Antimicrobials Global Market Report 2024 – By Type of Product (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins, Other Antimicrobials and Antibiotics), By Mode of Delivery (Premixes, Oral Powder, Oral Solution, Injection, Other Modes of Delivery), By Animal Type (Food-Producing Animals, Companion Animals) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Antibiotics Global Market Report 2024 – By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others), By End User (Farm Animals, Companion Animals), By Administration (Premixes, Injections, Oral Powders, Oral Solutions, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Pain Management Global Market Report 2024 – By Product (Drugs, Devices), By Animal Type (Companion Animals, Livestock), By Distribution Channel (Hospitals and Clinics, Pharmacy), By Application (Joint Pain, Postoperative Pain, Cancer, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Pharmaceuticals Global Market Report 2024 – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Veterinary Pharmaceuticals), By Type Of Animal (Livestock, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administration), By End User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Vaccines Global Market Report 2024 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Medical Equipment Global Market Report 2024 – By Type (Veterinary Diagnostic Equipment, Veterinary Anesthesia Equipment, Veterinary Patient Monitoring Equipment, Other Veterinary Medical Equipment), By Product (Instruments/Equipment, Disposables), By Animal Type (Small Companion Animals, Large Animals, Other Animals), By End User (Veterinary Hospitals, Veterinary Clinics, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Veterinary Healthcare Global Market Report 2024 – By Type (Veterinary Services, Veterinary Medical Equipment, Animal Medicine), By Product (Instruments/Equipment, Disposables), By Animal Type (Dogs and Cats, Horses, Ruminants, Swine, Poultry, Other Animals) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the rare kidney diseases market?

Rare kidney disease is a condition where kidneys aren't functioning correctly, waste accumulates in the body, and causes problems with your health. It is a set of renal diseases that have a low frequency in the general population, and these disorders frequently have a genetic or hereditary origin. For further insights on the rare kidney diseases market, request a sample here

How will the rare kidney diseases market drivers and restraints affect the rare kidney diseases market dynamics? What forces will shape the rare kidney diseases industry going forward?

The rare kidney diseases market major growth driver - Government Catalysts Fueling Rare Kidney Disease Market Surge. For further insights on the rare kidney diseases market, request a sample here

What is the forecast market size or the forecast market value of the rare kidney diseases market?

The rare kidney diseases market size has grown rapidly in recent years. It will grow from $2.52 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to increased disease recognition, orphan drug designations, patient advocacy and awareness, global collaborations in research.. The rare kidney diseases market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to emergence of gene therapies, increasing investment in rare disease research, growing collaboration between stakeholders, global initiatives for rare diseases.. Major trends in the forecast period include patient-centric approach, real-world evidence and data analytics, regulatory developments, telemedicine and remote monitoring, global health initiatives.. For further insights on the rare kidney diseases market, request a sample here

How is the rare kidney diseases market segmented?

The rare kidney diseases market is segmented
1) By Target Indication: IgA Nephropathy, Lupus Nephritis, Focal Segmental Glomerular Sclerosis, Membranous Nephropathy, C3 Glomerulopathy, Other Target Indications
2) By Type of Molecule: Small Molecules, Biologics
3) By Route of administration: Oral, Intravenous, Subcutaneous, Other Routes of AdministrationFor further insights on the rare kidney diseases market, request a sample here

Which region has the largest share of the rare kidney diseases market? What are the other regions covered in the report?

North America was the leading region in the rare kidney disease market in 2023. The regions covered in the rare kidney diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the rare kidney diseases market, request a sample here.

Who are the major players in the rare kidney diseases market?

Major companies operating in the rare kidney diseases market report are Merck & Co. Inc., Novartis AG, Sanofi S.A, AstraZeneca plc, GlaxoSmithKline plc, Otsuka Pharmaceutical Co Ltd., Alexion Pharmaceuticals Inc., Horizon Therapeutics plc., Recordati S.p.A., Proteostasis Therapeutics, Amicus Therapeutics Inc., Akebia Therapeutics Inc., Travere Therapeutics, FibroGen Inc., Aurinia Pharmaceuticals Inc., Calliditas Therapeutics AB, Apellis Pharmaceuticals Inc., Protalix Biotherapeutics Inc., ChemoCentryx Inc., Omeros Corporation, Celtaxsys Inc., Corbus Pharmaceuticals Holdings Inc., Chinook Therapeutics Inc., Spyryx Biosciences Inc., OxThera AB, Advicenne Pharma SA, ProQR Therapeutics NV, Reata Pharmaceuticals Inc., Savara Inc. For further insights on the rare kidney diseases market, request a sample here.

What are the key trends in the rare kidney diseases market?

Major trend in the rare kidney diseases market - Innovative Therapies Emerge As Key Catalysts In Rare Kidney Disease Market Evolution. For further insights on the rare kidney diseases market, request a sample here.

What are the major opportunities in the rare kidney diseases market? What are the strategies for the rare kidney diseases market?

For detailed insights on the major opportunities and strategies in the rare kidney diseases market, request a sample here.

How does the rare kidney diseases market relate to the overall economy and other similar markets?

For detailed insights on rare kidney diseases market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the rare kidney diseases industry?

For detailed insights on the mergers and acquisitions in the rare kidney diseases industry, request a sample here.

What are the key dynamics influencing the rare kidney diseases market growth? SWOT analysis of the rare kidney diseases market.

For detailed insights on the key dynamics influencing the rare kidney diseases market growth and SWOT analysis of the rare kidney diseases industry, request a sample here.